Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Calcium signaling pathway 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
2 Calcium signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
3 Calcium signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
4 Calcium signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
5 Calcium signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
6 Calcium signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
7 Calcium signaling pathway 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
8 Calcium signaling pathway 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
9 Calcium signaling pathway 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
10 Calcium signaling pathway 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
11 Calcium signaling pathway 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
12 Calcium signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
13 Calcium signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
14 Calcium signaling pathway 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
15 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
16 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
17 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
18 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
19 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
20 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
21 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
22 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
23 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
24 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
25 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
26 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
27 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
28 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
29 Focal adhesion 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
30 Focal adhesion 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
31 Focal adhesion 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
32 Focal adhesion 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
33 Focal adhesion 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
34 Focal adhesion 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
35 Focal adhesion 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
36 Focal adhesion 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
37 Focal adhesion 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
38 Focal adhesion 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
39 Focal adhesion 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
40 Focal adhesion 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
41 Focal adhesion 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
42 Focal adhesion 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
43 MAPK signaling pathway 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
44 MAPK signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
45 MAPK signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
46 MAPK signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
47 MAPK signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
48 MAPK signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
49 MAPK signaling pathway 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
50 MAPK signaling pathway 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
51 MAPK signaling pathway 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
52 MAPK signaling pathway 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
53 MAPK signaling pathway 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
54 MAPK signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
55 MAPK signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
56 MAPK signaling pathway 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
57 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
58 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
59 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
60 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
61 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
62 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
63 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
64 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
65 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
66 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
67 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
68 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
69 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
70 PI3K-Akt signaling pathway 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
71 Proteoglycans in cancer 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
72 Proteoglycans in cancer 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
73 Proteoglycans in cancer 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
74 Proteoglycans in cancer 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
75 Proteoglycans in cancer 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
76 Proteoglycans in cancer 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
77 Proteoglycans in cancer 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
78 Proteoglycans in cancer 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
79 Proteoglycans in cancer 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
80 Proteoglycans in cancer 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
81 Proteoglycans in cancer 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
82 Proteoglycans in cancer 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
83 Proteoglycans in cancer 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
84 Proteoglycans in cancer 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
85 Rap1 signaling pathway 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
86 Rap1 signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
87 Rap1 signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
88 Rap1 signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
89 Rap1 signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
90 Rap1 signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
91 Rap1 signaling pathway 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
92 Rap1 signaling pathway 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
93 Rap1 signaling pathway 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
94 Rap1 signaling pathway 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
95 Rap1 signaling pathway 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
96 Rap1 signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
97 Rap1 signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
98 Rap1 signaling pathway 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
99 Ras signaling pathway 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
100 Ras signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
101 Ras signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
102 Ras signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
103 Ras signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
104 Ras signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
105 Ras signaling pathway 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
106 Ras signaling pathway 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
107 Ras signaling pathway 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
108 Ras signaling pathway 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
109 Ras signaling pathway 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
110 Ras signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
111 Ras signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
112 Ras signaling pathway 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
113 VEGF signaling pathway 💬
1件: KDR 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
114 VEGF signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
115 VEGF signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
116 VEGF signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
117 VEGF signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
118 VEGF signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
119 VEGF signaling pathway 💬
1件: KDR 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
120 VEGF signaling pathway 💬
1件: KDR 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
121 VEGF signaling pathway 💬
1件: KDR 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
122 VEGF signaling pathway 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
123 VEGF signaling pathway 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
124 VEGF signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
125 VEGF signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
126 VEGF signaling pathway 💬
1件: KDR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬